HealthLynked (HLYK) Return on Equity (2017 - 2026)

HealthLynked has disclosed Return on Equity across 10 years of filings, most recently posting 0.0% for Q1 2026.

• In Q1 2026, Return on Equity fell 1.0% year-over-year to 0.0%; the TTM figure through Mar 2026 stood at 0.0% (down 1.0% YoY), while the FY2025 annual figure was 0.0%, down 4.0% from the prior year.
• Return on Equity eased to 0.0% in Q1 2026, from 0.0% in the prior quarter.
• Over the last five years, Return on Equity for HLYK reached as high as 0.22% in Q2 2024 and fell as low as 0.02% in Q1 2024.
• The 5-year median for Return on Equity is 0.01% (2025), against an average of 0.02%.
• Annual changes were most pronounced in 2024 — Return on Equity rose 21 bps — and 2025, when it decreased 22 bps.
• A 5-year view of Return on Equity shows it stood at 0.0% in 2022, then jumped by 739 bps to 0.02% in 2023, then fell by 16 bps to 0.02% in 2024, then tumbled by 80 bps to 0.0% in 2025, then retreated by 9 bps to 0.0% in 2026.
• According to Business Quant data, Return on Equity over the past three periods registered 0.0%, 0.0%, and 0.0% for Q1 2026, Q4 2025, and Q3 2025 respectively.